l 659989 has been researched along with Glomerulonephritis, Lupus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertani, T; Boccardo, P; Macconi, D; Morigi, M; Remuzzi, G; Riccardi, E; Zilio, P | 1 |
| Baldi, E; Dunn, MJ; Emancipator, SN; Hassan, MO | 1 |
2 other study(ies) available for l 659989 and Glomerulonephritis, Lupus
| Article | Year |
|---|---|
Platelet-activating factor receptor blocking reduces proteinuria and improves survival in lupus autoimmune mice.
Topics: Animals; Blood Urea Nitrogen; Female; Furans; Kidney; Lupus Nephritis; Mice; Mice, Inbred NZB; Platelet Activating Factor; Platelet Membrane Glycoproteins; Proteinuria; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Survival Rate | 1991 |
Platelet activating factor receptor blockade ameliorates murine systemic lupus erythematosus.
Topics: Animals; Female; Furans; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Mice; Mice, Inbred Strains; Platelet Activating Factor; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled | 1990 |